ArticleInternational neurourology journal2019

A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy.

Ho Song Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.